Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells

Mol Nutr Food Res. 2012 Jun;56(6):923-34. doi: 10.1002/mnfr.201200027.

Abstract

Scope: Docosahexaenoic acid (DHA) has been shown to exhibit anticancer actions in vitro and in vivo in a variety of cancers. Here, we investigated the role for DHA in inducing apoptosis in triple-negative breast cancer (TNBC) and studied the mechanisms of action.

Methods and results: DHA induces apoptosis as detected by Annexin V-FITC/PI assay as well as induces cleavage of caspase-8 and -9, endoplasmic reticulum stress (ERS), and elevated levels of death receptor-5 (DR5) protein expression as detected by western blot assays. Chemical inhibitors of caspase-8 and -9 and small interfering RNAs (siRNAs) show DHA to induce ERS/CHOP/DR5-mediated caspase-8 and -9 dependent apoptosis. Furthermore, DHA induces elevated cellular levels of reactive oxygen species (ROS) and antioxidant; RRR-α-tocopherol (αT) blocked DHA-induced apoptotic events. In contrast to the antagonistic impact of αT, gamma-tocotrienol (γT3) was demonstrated to cooperate with DHA in inducing apoptotic events in TNBC cells.

Conclusion: Data, for the first time, demonstrate that DHA induces apoptosis in TNBC cells via activation of ERS/CHOP/DR5-mediated caspase-8 and -9 dependent pro-apoptotic events, and that different forms of vitamin E exhibit distinct effects on DHA-induced apoptosis; namely, inhibition by αT and enhancement by γT3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / agonists
  • Antineoplastic Agents / antagonists & inhibitors
  • Antineoplastic Agents / metabolism*
  • Antineoplastic Agents / pharmacology
  • Antioxidants / metabolism*
  • Antioxidants / pharmacology
  • Apoptosis* / drug effects
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / metabolism*
  • Caspase Inhibitors
  • Caspases, Initiator / metabolism
  • Cell Line, Tumor
  • Chromans / pharmacology
  • Cysteine Proteinase Inhibitors / pharmacology
  • Docosahexaenoic Acids / agonists
  • Docosahexaenoic Acids / antagonists & inhibitors
  • Docosahexaenoic Acids / metabolism*
  • Endoplasmic Reticulum Stress / drug effects
  • Female
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Neoplasm Proteins / antagonists & inhibitors
  • Neoplasm Proteins / genetics
  • Neoplasm Proteins / metabolism
  • RNA Interference
  • RNA, Messenger / metabolism
  • RNA, Small Interfering
  • Reactive Oxygen Species / antagonists & inhibitors
  • Reactive Oxygen Species / metabolism
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / antagonists & inhibitors
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / genetics
  • Receptors, TNF-Related Apoptosis-Inducing Ligand / metabolism
  • Transcription Factor CHOP / antagonists & inhibitors
  • Transcription Factor CHOP / genetics
  • Transcription Factor CHOP / metabolism
  • Vitamin E / analogs & derivatives*
  • Vitamin E / metabolism
  • Vitamin E / pharmacology
  • alpha-Tocopherol / metabolism

Substances

  • Antineoplastic Agents
  • Antioxidants
  • Caspase Inhibitors
  • Chromans
  • Cysteine Proteinase Inhibitors
  • DDIT3 protein, human
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Small Interfering
  • Reactive Oxygen Species
  • Receptors, TNF-Related Apoptosis-Inducing Ligand
  • Vitamin E
  • Transcription Factor CHOP
  • Docosahexaenoic Acids
  • plastochromanol 8
  • Caspases, Initiator
  • alpha-Tocopherol